EXPEDIA GROUP INC (EXPE)

US30212P3038 - Common Stock

186.52  +3.33 (+1.82%)

After market: 186.52 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to EXPE. EXPE was compared to 134 industry peers in the Hotels, Restaurants & Leisure industry. While EXPE has a great profitability rating, there are quite some concerns on its financial health. EXPE is valued quite cheap, while showing a decent growth score. This is a good combination!



7

1. Profitability

1.1 Basic Checks

In the past year EXPE was profitable.
In the past year EXPE had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: EXPE reported negative net income in multiple years.
Of the past 5 years EXPE 4 years had a positive operating cash flow.

1.2 Ratios

The Return On Assets of EXPE (4.53%) is better than 66.41% of its industry peers.
The Return On Equity of EXPE (80.26%) is better than 98.47% of its industry peers.
The Return On Invested Capital of EXPE (11.64%) is better than 77.10% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EXPE is below the industry average of 10.54%.
The last Return On Invested Capital (11.64%) for EXPE is above the 3 year average (6.14%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.53%
ROE 80.26%
ROIC 11.64%
ROA(3y)1.36%
ROA(5y)-1.53%
ROE(3y)18.1%
ROE(5y)-7.52%
ROIC(3y)6.14%
ROIC(5y)N/A

1.3 Margins

With a decent Profit Margin value of 7.92%, EXPE is doing good in the industry, outperforming 67.18% of the companies in the same industry.
EXPE's Profit Margin has improved in the last couple of years.
EXPE's Operating Margin of 11.41% is in line compared to the rest of the industry. EXPE outperforms 56.49% of its industry peers.
In the last couple of years the Operating Margin of EXPE has grown nicely.
EXPE's Gross Margin of 89.17% is amongst the best of the industry. EXPE outperforms 99.24% of its industry peers.
EXPE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.41%
PM (TTM) 7.92%
GM 89.17%
OM growth 3YN/A
OM growth 5Y10.37%
PM growth 3YN/A
PM growth 5Y11.4%
GM growth 3Y9.04%
GM growth 5Y1.24%

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), EXPE is creating some value.
The number of shares outstanding for EXPE has been reduced compared to 1 year ago.
EXPE has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, EXPE has about the same debt to assets ratio.

2.2 Solvency

EXPE has an Altman-Z score of 1.24. This is a bad value and indicates that EXPE is not financially healthy and even has some risk of bankruptcy.
EXPE's Altman-Z score of 1.24 is in line compared to the rest of the industry. EXPE outperforms 41.22% of its industry peers.
EXPE has a debt to FCF ratio of 3.28. This is a good value and a sign of high solvency as EXPE would need 3.28 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.28, EXPE is in the better half of the industry, outperforming 79.39% of the companies in the same industry.
EXPE has a Debt/Equity ratio of 3.95. This is a high value indicating a heavy dependency on external financing.
EXPE has a Debt to Equity ratio of 3.95. This is comparable to the rest of the industry: EXPE outperforms 43.51% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.95
Debt/FCF 3.28
Altman-Z 1.24
ROIC/WACC1.46
WACC7.97%

2.3 Liquidity

A Current Ratio of 0.73 indicates that EXPE may have some problems paying its short term obligations.
The Current ratio of EXPE (0.73) is worse than 62.60% of its industry peers.
A Quick Ratio of 0.73 indicates that EXPE may have some problems paying its short term obligations.
EXPE's Quick ratio of 0.73 is in line compared to the rest of the industry. EXPE outperforms 42.75% of its industry peers.
Industry RankSector Rank
Current Ratio 0.73
Quick Ratio 0.73

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 23.61% over the past year.
EXPE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.07% yearly.
EXPE shows a small growth in Revenue. In the last year, the Revenue has grown by 6.56%.
Measured over the past years, EXPE shows a small growth in Revenue. The Revenue has been growing by 2.73% on average per year.
EPS 1Y (TTM)23.61%
EPS 3YN/A
EPS 5Y11.07%
EPS Q2Q%13.31%
Revenue 1Y (TTM)6.56%
Revenue growth 3Y35.17%
Revenue growth 5Y2.73%
Sales Q2Q%3.33%

3.2 Future

The Earnings Per Share is expected to grow by 14.71% on average over the next years. This is quite good.
EXPE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.51% yearly.
EPS Next Y22.39%
EPS Next 2Y20.97%
EPS Next 3Y20.88%
EPS Next 5Y14.71%
Revenue Next Year5.8%
Revenue Next 2Y6.85%
Revenue Next 3Y6.84%
Revenue Next 5Y6.51%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 16.12, which indicates a correct valuation of EXPE.
79.39% of the companies in the same industry are more expensive than EXPE, based on the Price/Earnings ratio.
EXPE is valuated rather cheaply when we compare the Price/Earnings ratio to 27.63, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 12.98, the valuation of EXPE can be described as correct.
Based on the Price/Forward Earnings ratio, EXPE is valued cheaper than 84.73% of the companies in the same industry.
EXPE's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.76.
Industry RankSector Rank
PE 16.12
Fwd PE 12.98

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EXPE is valued a bit cheaper than 65.65% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, EXPE is valued cheaply inside the industry as 90.08% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.55
EV/EBITDA 10.44

4.3 Compensation for Growth

EXPE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EXPE has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as EXPE's earnings are expected to grow with 20.88% in the coming years.
PEG (NY)0.72
PEG (5Y)1.46
EPS Next 2Y20.97%
EPS Next 3Y20.88%

0

5. Dividend

5.1 Amount

EXPE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EXPEDIA GROUP INC

NASDAQ:EXPE (1/15/2025, 5:20:01 PM)

After market: 186.52 0 (0%)

186.52

+3.33 (+1.82%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-06 2025-02-06/amc
Inst Owners98.77%
Inst Owner Change-0.06%
Ins Owners0.49%
Ins Owner Change-0.17%
Market Cap23.94B
Analysts71.36
Price Target190 (1.87%)
Short Float %4.59%
Short Ratio3.93
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.75%
Min EPS beat(2)-0.95%
Max EPS beat(2)12.45%
EPS beat(4)3
Avg EPS beat(4)49.72%
Min EPS beat(4)-0.95%
Max EPS beat(4)187.08%
EPS beat(8)5
Avg EPS beat(8)-22.96%
EPS beat(12)8
Avg EPS beat(12)-7.24%
EPS beat(16)10
Avg EPS beat(16)-4.01%
Revenue beat(2)0
Avg Revenue beat(2)-2.26%
Min Revenue beat(2)-3.22%
Max Revenue beat(2)-1.3%
Revenue beat(4)1
Avg Revenue beat(4)-1.31%
Min Revenue beat(4)-3.22%
Max Revenue beat(4)0.87%
Revenue beat(8)1
Avg Revenue beat(8)-1.79%
Revenue beat(12)2
Avg Revenue beat(12)-1.28%
Revenue beat(16)5
Avg Revenue beat(16)-0.92%
PT rev (1m)0.94%
PT rev (3m)25.66%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.94%
EPS NY rev (1m)0.16%
EPS NY rev (3m)-0.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.36%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)-0.52%
Valuation
Industry RankSector Rank
PE 16.12
Fwd PE 12.98
P/S 1.79
P/FCF 12.55
P/OCF 9.04
P/B 18.11
P/tB N/A
EV/EBITDA 10.44
EPS(TTM)11.57
EY6.2%
EPS(NY)14.37
Fwd EY7.7%
FCF(TTM)14.86
FCFY7.97%
OCF(TTM)20.64
OCFY11.07%
SpS104.36
BVpS10.3
TBVpS-50.46
PEG (NY)0.72
PEG (5Y)1.46
Profitability
Industry RankSector Rank
ROA 4.53%
ROE 80.26%
ROCE 17.73%
ROIC 11.64%
ROICexc 27.12%
ROICexgc N/A
OM 11.41%
PM (TTM) 7.92%
GM 89.17%
FCFM 14.24%
ROA(3y)1.36%
ROA(5y)-1.53%
ROE(3y)18.1%
ROE(5y)-7.52%
ROIC(3y)6.14%
ROIC(5y)N/A
ROICexc(3y)10.39%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)9.36%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5Y20.18%
OM growth 3YN/A
OM growth 5Y10.37%
PM growth 3YN/A
PM growth 5Y11.4%
GM growth 3Y9.04%
GM growth 5Y1.24%
F-Score8
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 3.95
Debt/FCF 3.28
Debt/EBITDA 2.21
Cap/Depr 88.97%
Cap/Sales 5.54%
Interest Coverage 6.61
Cash Conversion 112.15%
Profit Quality 179.74%
Current Ratio 0.73
Quick Ratio 0.73
Altman-Z 1.24
F-Score8
WACC7.97%
ROIC/WACC1.46
Cap/Depr(3y)90.37%
Cap/Depr(5y)94.64%
Cap/Sales(3y)6.7%
Cap/Sales(5y)9.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.61%
EPS 3YN/A
EPS 5Y11.07%
EPS Q2Q%13.31%
EPS Next Y22.39%
EPS Next 2Y20.97%
EPS Next 3Y20.88%
EPS Next 5Y14.71%
Revenue 1Y (TTM)6.56%
Revenue growth 3Y35.17%
Revenue growth 5Y2.73%
Sales Q2Q%3.33%
Revenue Next Year5.8%
Revenue Next 2Y6.85%
Revenue Next 3Y6.84%
Revenue Next 5Y6.51%
EBIT growth 1Y11.13%
EBIT growth 3YN/A
EBIT growth 5Y13.38%
EBIT Next Year129.5%
EBIT Next 3Y40.67%
EBIT Next 5Y26.47%
FCF growth 1Y-41.84%
FCF growth 3YN/A
FCF growth 5Y10.95%
OCF growth 1Y-32.2%
OCF growth 3YN/A
OCF growth 5Y6.37%